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Acrylamide quenchingHepatitis C virus encodes an autoprotease, NS2-3, which is required for processing of the viral polyprotein
between the non-structural NS2 and NS3 proteins. This protease activity is vital for the replication and
assembly of the virus and therefore represents a target for the development of anti-viral drugs. The
mechanism of this auto-processing reaction is not yet clear but the protease activity has been shown to map
to the C-terminal region of NS2 and the N-terminal serine protease region of NS3. The NS2-3 precursor can
be expressed in Escherichia coli as inclusion bodies, puriﬁed as denatured protein and refolded, in the
presence of detergents and the divalent metal ion zinc, into an active form capable of auto-cleavage. Here,
intrinsic tryptophan ﬂuorescence has been used to assess refolding in the wild-type protein and speciﬁc
active site mutants. We also investigate the effects on protein folding of alterations to the reaction conditions
that have been shown to prevent auto-cleavage. Our data demonstrate that these active site mutations do
not solely affect the cleavage activity of the HCV NS2-3 protease but signiﬁcantly affect the integrity of the
global protein fold.
© 2009 Elsevier B.V. Open access under CC BY license.1. Introduction
Hepatitis C virus (HCV) currently infects an estimated 170 million
individuals worldwide; in approximately 80% of these cases, the virus
establishes a chronic infection that leads to liver cirrhosis and hepato-
cellular carcinoma [1]. HCV infection is a growing health problem
with an estimated three to four million individuals becoming newly
infected each year. HCV infection is the leading indicator for liver
transplantation in the developed world therefore research into
identifying targets for therapeutic intervention is vital and has been
stimulated by the limited ineffective therapy options and the lack of
vaccines. [1,2].
HCV is an enveloped virus with a positive sense RNA genome of
9.6 kb consisting of a 5′-untranslated region (UTR) which includes an
internal ribosome entry site (IRES), a single open reading frame (ORF)
that encodes the structural and non-structural viral proteins and a 3′-
UTR [2-5]. Cap-independent translation of the viral genome yields a
large polyprotein of approximately 3000 amino acid residues [5,6].
Co-translational and post-translational processing of the polyprotein
by host signal peptidases and two viral proteases at the endoplasmic
reticulum (ER) results in 10 mature virus proteins; these cleavageural; JFH-1, Japanese fulminant
HCl, guanidine hydrochloride;
ethylammonio]-1-propanesul-
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 license.products are ordered from the amino to the carboxy terminus as
follows: core (C), envelope protein 1 (E1), E2, p7, non-structural pro-
tein 2 (NS2), NS3, NS4A, NS4B, NS5A and NS5B (Fig. 1A) [2,5-7]. Host
signal peptidase cleaves the precursor polyprotein at the Core/E1, E1/
E2, E2/p7 and p7/NS2 junctions [8], while the HCV-encoded NS3-
NS4A serine protease complex cleaves the junctions of non-structural
proteins NS3-5B [9]. Auto-processing by the virally encoded NS2-3
protease is responsible for cleavage at the NS2/NS3 junction; this
activity has been demonstrated to be essential for replication of full-
length virus and subgenomic replicons that span the NS2-NS5B region
(Fig. 1A) [10,11]. Auto-cleavage by NS2-3 is a key step in the viral life
cycle and is therefore a potential drug target, but little is known
regarding its pre-cleavage protein structure, molecular mechanism
and the regulation of this process.
Auto-cleavage of the NS2-3 precursor at the NS2/3 junction results
in the release of the NS2 and NS3 proteins. NS2 is a 217 residue
protein; the N-terminal 96 residues are highly hydrophobic and are
proposed to form either three or four transmembrane helices that
insert into the ER membrane [12]. The C-terminal region of NS2
resides in the cytoplasm and, together with the N-terminal region of
the serine protease NS3, forms the NS2-3 autoprotease. This region
(amino acids 907-1210 in HCV genotype 2a), mapped through trun-
cation analyses, is the minimal region required for activity; NS2-3
cleavage activity occurs independently of NS3 protease activity
(Fig. 1B) [13].
Biochemical andmutational characterisation has identiﬁed several
determinants of NS2-3 cleavage [10-13]. In vitro processing at the
NS2-3 site requires the presence of microsomal membranes or
Fig. 1. (A) Schematic representation of the HCV polyprotein. The HCV genome is translated into the structural proteins located at the N-terminus and the non-structural proteins at
the C-terminus. Distances along the polyprotein are shown in amino acid residues. UTR, untranslated region; IRES, internal ribosomal entry site; E, envelope glycoprotein; NS, non-
structural protein. Processing of the polyprotein precursor in the structural region and at the N-terminus of NS2 is mediated by host signal peptidase. The virus-encoded protease
NS3 is responsible for further cleavages in the non-structural region of the polyprotein. The NS2–NS3 junction is cleaved by the NS2/3 autoprotease (denoted by the black cyclic
arrow). (B) Schematic representation of the NS2-3 cleavage site. The region from residues 907–1210maps to theminimal region required for autoproteolysis; numbering is based on
the HCV genotype 2a JFH-1 isolate. This fragment was expressed with N-terminal hexahistidine and C-terminal FLAG-tags. The active site residues at which single point mutations
were made in NS2 are labelled. (C) The active site of the domain swapped NS2 post-cleavage dimer of genotype 1a NS2-3. The ﬁgure was generated using Pymol version 0.99 and the
coordinates of PDB code 2hd0 [20]. Residues His952, Glu972 and Cys993 are shown in stick representation. Carbon and backbone ribbon are coloured in black for monomer A and
grey for monomer B. The C-terminal main chain of LLeu1026 of monomer B is coordinated to H952 and C993 in the post-cleavage domain swapped NS2-3 dimer.
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the correct folding of the protease and for the subsequent cleavage. An
in vitro assay based on the dilution of reduced and denatured NS2-3
into a cleavage buffer which contains high salt and glycerol as well as
zwitterionic or non-ionic detergents can be used to assess cleavage of
the NS2-3 junction by western blotting. The resulting in vitro cleavage
is temperature sensitive and cleavage is greatly retarded at tempera-
tures above 30 °C and below 15 °C [14-18].
Mutations around the highly conserved cleavage site 1023-
WRLL⁎APIT-1030 are well tolerated, except for mutations that
speciﬁcally disrupt the conformation of the NS2/3 junction such as
the substitution of leucine and alanine for proline which rigidiﬁes
the peptide [16]. The serine protease activity of the mature NS3
protein is not required for the NS2-3 cleavage reaction; however,
mutation of the three cysteine residues (Cys1123, Cys1125, Cys1171),
which in the NS3 structure along with a histidine residue (His1175)
are involved in the tetrahedral coordination of a Zn2+ ion, completely
abolishes NS2-3 activity [10,13]. In addition, the activity of the
enzyme can be inhibited by the presence of EDTA and stimulated bythe addition of excess zinc further suggesting that the structural role
of the coordinated Zn2+ ion is functionally important for NS2-3
activity [13]. Site-directed mutagenesis studies have identiﬁed two
distinct residues within NS2 alone which are important for the
activation of the protease, numbered in genotype 1b as His952 and
Cys993 [13,15,17,18], and recently, an intrinsic basal enzymatic acti-
vity of NS2, followed by only two amino acids of NS3, has been
identiﬁed, conﬁrming that NS2 alone possesses proteolytic activity
with NS3 acting as a stimulatory cofactor [19].
The three-dimensional structure of the N-terminal truncated NS2
portion (residues 904–1026 of genotype 1a) of the NS2-3 enzyme has
been elucidated (Fig. 1C) [20]. It represents the post-cleavage state
of the enzyme, as the C-terminal Leu1026 is coordinated within
the proposed active site. It shows that NS2 forms a homodimer with
two composite active sites: residues His952 and Glu972 from one
monomer and Cys993 from the other [17-20]. From this crystal
structure, it was proposed that NS2 is a cysteine protease based on the
similarities in the spatial arrangement of these active site residues to
known cysteine proteases such as papain and poliovirus 3C protease
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site are conserved between genotypes and mutations within this site
result in inhibition of in vitro cleavage of the NS2-3 precursor (Fig. 1C)
[13,14-16]. However, in the absence of the zinc-coordinating NS3
protease domain, this structure solely represents the post-cleavage
state of the enzyme and raises questions, due to its dimeric nature,
about the molecular level at which cleavage occurs during translation
and polyprotein processing.
Key questions concerning NS2-3 biology relate to the under-
standing of the autoprotease mechanism and the structural changes
that occur to accommodate cleavage. Current knowledge of the
structural features of the NS2-3 precursor is very poor. This is mainly
due to the strict conditions required for NS2-3 cleavage in vitro; i.e.,
high salt, glycerol and detergent content which often hampers X-ray
crystallography and NMR spectroscopy techniques. The identiﬁcation
of active site residues, His952 and Cys993, which on mutation
abrogate cleavage has aided some understanding of the activity of
NS2-3 and are therefore targets for structural information on the pre-
cleavage state of the enzyme. The effects these mutations have on
the conformational rearrangement of the catalytically active precur-
sor, i.e., the correct fold of the precursor state have not been
addressed.
Here, we analysed the NS2-3 protease of genotype 2a isolate JFH-1
with selected NS2-3 point mutants, biochemically and by tryptophan
ﬂuorescence spectroscopy. This technique was used to independently
assess the cleavage and folding of the wild-type and mutant
autoprotease proteins to investigate conformational changes that
occur upon refolding and to investigate global differences between
the folds of the autoproteases showing that loss of enzymatic function
is often associated with loss of protein folding.
2. Materials and methods
2.1. Expression and puriﬁcation of recombinant NS2-3 autoprotease
The preparation of the JFH-1 NS2-3 wild-type and protease
mutants His956-Ala (H956A) and Cys997-Ala (C997A), equivalent
to H952A and C993A in the genotype 1b J4 isolate, and their ex-
pression via the modiﬁed pET23a vector in Escherichia coli BL21 (DE3)
pLysS, has been described previously [13,18]. Brieﬂy, E. coli BL21
(DE3) pLysS cells, harbouring the pET23a-NS2-3 constructs, were
grown in LB medium supplemented with 1% glucose and 50 μg/μl
ampicillin. Overexpression was induced at OD600=1 by the addition
of 1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) and cells
were grown for a further 3 h at 37 °C. The overexpressed proteins
were recovered in inclusion bodies and solubilised in extraction buffer
(6 M GdnHCl, 0.5 M NaCl, 50 mM Tris–HCl, pH 8.0) [13,18]. The
inclusion bodies were clariﬁed by centrifugation at 40 000×g for 1 h
and the supernatant passed through a 0.22-μm ﬁlter. The ﬁltrate was
diluted 1:1 with extraction buffer supplemented with 40 mM
imidazole and added to 1 ml of pre-charged chelating sepharose
resin per 30 ml sample (Chelating Sepharose™ Fast Flow—Amersham
Biosciences; the resinwas chargedwith Ni2+ prior to use, according to
manufacturer's instructions). The sample was incubated for 1 h at 4 °C
then the resin was pelleted by centrifugation for 2min at 1500×g . The
resin was washed by resuspension and mixing for 5 min at 4 °C, twice
in 10 ml extraction buffer and three times in 10 ml wash buffer (6 M
GdnHCl (Sigma), 0.5 M NaCl, 50 mM imidazole, 50 mM Tris–HCl, pH
8). The protein was then eluted by resuspension and mixing for 5 min
at 4 °C in 5 ml elution buffer (6 M GdnHCl, 0.5 M NaCl, 500 mM
imidazole, 50 mM Tris–HCl, pH 8).
2.2. NS2-3 protease auto-cleavage assay
Denatured NS2-3 was supplemented with 100 mM DTT before
diluting 1:100 with cleavage buffer that supports refolding (30%glycerol, 0.5% CHAPS, 250 mM NaCl, 3 mM cysteine, 50 μM ZnCl2,
50 mM HEPES–NaOH, pH 7). The reaction was incubated overnight at
room temperature and stopped by the addition of an equal volume of
2× Laemmli sample buffer (100 mM Tris–HCl pH 6.8, 20% glycerol, 4%
SDS, 0.04% bromophenol blue, 10mMDTT). The cleavage reactionwas
analysed by 15% SDS–PAGE and western blot using M2 anti-FLAG
monoclonal antibody (Sigma), followed by an HRP-conjugated goat
anti-mouse antibody (Sigma). Where appropriate, western blotting
was performed with sheep polyclonal sera raised to NS3 followed by
an HRP-conjugated donkey anti-sheep antibody (Sigma).
2.3. Glutaraldehyde cross-linking reactions
Glutaraldehyde cross-linking was performed by incubating
refolded NS2-3 precursor (0.2 μM) with freshly prepared glutaralde-
hyde solution (Sigma, ﬁnal concentrations, 0.001–0.002% [v/v] in
refolding buffer) in a 50-μl reaction mixture at 25 °C for 5 min. The
reaction was quenched by the addition of an equal volume of 2×
Laemmli sample buffer before cross-linked products were analysed by
SDS–PAGE andwestern blot usingM2 anti-FLAGmonoclonal antibody
(Sigma), followed by an HRP-conjugated goat anti-mouse antibody
(Sigma).
2.4. Tryptophan ﬂuorescence spectroscopy
All tryptophan ﬂuorescence emission spectra were recorded on a
Fluorolog®-3 (HORIBA JOBIN YVON) ﬂuorescence spectrometer. Slit
widths of 3 nm were used on the emission monochromator and
temperatures were set to 25 °C or 4 °C accordingly. The protein
concentration used for measurements was 50 μM. Measurements
were performed in a 10-mm path length cell by illuminating NS2-3
precursor samples with 295-nm wavelength light in order to
selectively excite the tryptophan residues of the protein. The emission
spectra were recorded between 290 and 500 nm.
2.5. Circular dichroism measurements
CD measurements were recorded on a Jasco J175 spectropolari-
meter (Jasco International Co. Ltd) equipped with a Peltier thermo-
stat. The concentration of the protein used was maintained at 6 μM in
the denaturing buffer or refolding buffer for measurements in the far-
UV region (200–260 nm). For the refolding conditions, HEPES buffer
was replaced by 50 mM sodium phosphate pH 7.0 and 100 mM DTT
was substituted by 10 mM beta-mercaptoethanol. Measurements
were recorded in a 1mmpath length cell with 0.5-nm increments and
4-s integration times and averaged over 3 scans. Buffer subtraction
was used for baseline correction and spectral units were converted to
molar ellipticity per residue using the protein concentrations
determined by amino acid analysis.
2.6. Acrylamide quenching studies
For quenching of intrinsic tryptophan ﬂuorescence, aliquots of 5 M
quencher stocks of the external quencher acrylamide (Sigma)
prepared in either 6 M GdnHCl, 100 mM Tris–HCl, pH 8.0, or in NS2-
3 cleavage buffer were added to the protein samples and ﬂuorescence
spectra were recorded after each addition. The ﬁnal quencher
concentration attained in each case was 0.5 M. Each quenching
reaction was set up separately to account for dilution effects and
reactions were performed in triplicate at 4 °C. The quenching data
were analysed by the Stern–Volmer equation: F0/F=1+KSV[Q],
where F and F0 are the relative unquenched and quenched intensities,
KSV is the Stern–Volmer constant and Q is the concentration of the
quencher in solution. For a heterogeneous population of emitting
ﬂuorophores, the plot of F0/F versus [Q] is non-linear. To estimate the
fraction of accessible ﬂuorophore quenched with a Stern–Volmer
Fig. 2. Comparative analyses of recombinant WT NS2-3 precursor proteins derived from J4 or JFH-1 isolates. (A) The cleavage activity of the J4 and JFH-1 precursors was probed by
western blotting using anti-NS3 polyclonal sera and anti-FLAGmonoclonal antibody. Genotype 2a JFH-1 NS2-3 lacks the truncation product of genotype 1b J4 NS2-3 detected by anti-
NS3 antibody. The black triangle indicates the NS3 cleavage product while the red triangle indicates the truncation product observed in J4 NS2-3. (B) Sequence alignment from
Clustal W2 multiple alignment of genotype 1b strain J4 NS2-3 (GenBank accession no. AF054250) and genotype 2a strain JFH-1 NS2-3 (GenBank accession no. AB047639). The
tryptophan ﬂuorophores are highlighted in yellow and the cleavage site in cyan and active site residues in magenta. (C) The pH of the cleavage buffer was varied by 0.5 pH units
within the range from pH 6.0 to pH 9.0 to assess the dependence of cleavage activity on pH for the two proteins. (D) The temperature dependence of cleavage activity between J4 and
JFH-1 NS2-3 was compared over a 16-h period. Optimal activity at 24 °C for both proteins and inactivity of JFH-1 at 4 °C compared to J4 as observed. (E) The inhibition of auto-
processing of NS2-3 by the chelation of metal ions was assessed by the addition of EDTA, EGTA and 1,10-phenanthroline (1,10-phen) to the cleavage reactions at 1 mM
concentrations. (F) Wild-type NS2-3 precursor and the two active site mutants H956A and C997A were expressed and puriﬁed by nickel afﬁnity chromatography and analysed by
15% SDS–PAGE followed by Coomassie staining. For auto-processing, puriﬁed wild-type NS2-3 precursor or the two mutants H956A and C997A were supplemented with 100 mM
DTT, diluted 1:100 into cleavage buffer and incubated at 25 °C or 4 °C. For all data in panels C–F apart from the Coomassie stained gel in panel F, the products were separated by SDS–
PAGE and probed by western blotting with anti-FLAG monoclonal antibody. Black triangles indicate the NS2-3 precursor and the NS3 protease domain cleavage product.
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Fig. 3. Glutaraldehyde cross-linking of refolded NS2-3 precursors. To analyse the
dimerisation of NS2-3, the protein was treated with increasing concentrations of
glutaraldehyde (ﬁnal concentration 0.0001 to 0.002% [v/v]) and the NS2-3 protein
complexes were analysed by SDS–PAGE and western blot.
216 T.L. Foster et al. / Biochimica et Biophysica Acta 1804 (2010) 212–222constant KSV, modiﬁed Stern–Volmer plots were used, as according to
Lehrer and Leavis [21]:
(F0/(F0− F)=1/[Q]faKSV+1/ fa), where fa is the fractional
accessible ﬂuorescence determined from a plot of F0/(F0− F)
versus 1/[Q].
3. Results
3.1. Characterisation of JFH-1 NS2-3 precursor
Previous biochemical studies of the NS2-3 protease have been
performed with protein of the genotype 1b J4 isolate. One
complication of the analysis of the activity and folding of J4 NS2-3
is the presence of a 30-kDa C-terminal truncation product of the full-
length protease (Fig. 2A) [13], which is detectable with NS3 antisera
but not detectable with the FLAG antisera, as the truncation lacks the
FLAG-tag located at the C-terminus of the full-length protein. This
abundant truncation product is non-functional but would contribute
signiﬁcantly to the data collected in analyses of the global folding of
the sample by tryptophan ﬂuorescence. This truncation product,
however, is not detectable in preparations of JFH-1 NS2-3, making
the NS2-3 protease from genotype 2a more suitable for the sub-
sequent assessment of refolding of the functional, full-length pre-
cursor state.
Sequence alignment of the two proteins of differing genotype
showed that there is high conservation of amino acid sequence in 67%
of sequence positions (denoted by asterisks in Fig. 2B), with absolute
conservation of the protease active site residues of NS2 and NS3, the
cleavage site of the NS2-3 precursor and the positions of the
tryptophan ﬂuorophores. We have demonstrated through compara-
tive analyses of the puriﬁed recombinant NS2-3 autoproteases from
J4 and JFH-1 isolates that the proteins exhibit similar characteristics
in terms of auto-cleavage requirements and efﬁciency. As shown in
Fig. 2C, both J4 and JFH-1 autoproteases are active across a wide pH
range with the highest cleavage activity observed between pH 7.0
and 8.0. Protease activity for both precursors is sensitive at and above
30 °C; however, J4 retains the ability to auto-cleave at 4 °C, while
there is no activity of the JFH-1 protein at this temperature (Fig. 2D).
Whether this inactivity is related to protein misfolding will be
investigated later in the article. The activity of NS2-3 is sensitive to
the chelation of the Zn2+ ion from NS3. The inhibition of cleavage of
the two NS2-3 precursors by Zn2+ chelation was demonstrated using
EDTA, 1,10-phenanthroline, both chelators of divalent metal ions and
EGTA, a chelator with preference for calcium ions, all at 1 mM con-
centration. 1,10-phenanthroline does not, however, chelate calcium
or magnesium ions. As demonstrated in Fig. 2E, unlike EDTA and
1,10-phenanthroline, EGTA does not inhibit auto-cleavage of either
J4 or JFH-1 NS2-3, suggesting that Zn2+ coordination is important in
the structural conformation and stability of the JFH-1 NS2-3
precursor [13]. As a result of these similarities with the genotype
1b J4 isolate, JFH-1 NS2-3 has been used for all spectroscopy data
reported here.
3.2. Functional refolding of WT NS2-3 autoprotease
Wild-type (WT) NS2-3 precursor and H956A and C997A mutants
were expressed in E. coli as N-terminal hexahistidine-tagged and C-
terminal FLAG-tagged recombinant proteins. The proteins, of appar-
ent molecular mass 35 kDa, were puriﬁed from insoluble inclusion
bodies by solubilisation in GdnHCl and metal chelate afﬁnity
chromatography, as described previously (Fig. 2F) [13].
NS2-3 auto-cleavage was stimulated by dilution into a cleavage
buffer which allowed refolding of the enzyme. Denatured NS2-3
precursor in 6 M GdnHCl, at 50 μM concentration, was ﬁrst treated
with 100 mM DTT to completely eliminate non-speciﬁc protein–protein interactions that contribute to aggregation. This denatured
and reduced protein was then diluted 100-fold into cleavage buffer
and incubated at 25 °C overnight. The efﬁciency of auto-cleavage of
the refolded NS2-3 protein, at low protein concentrations, was
monitored by western blotting (Fig. 2F, right-hand panel), with the
appearance of the 19-kDa C-terminal NS3 fragment, detectable with
antibodies to NS3 or the FLAG-tag, indicating successful auto-
cleavage. The active site mutants H956A and C997A are shown to be
inactive [10,11,15], as no cleavage product is observed upon com-
parison with the processing of the WT protein, which has an in vitro
cleavage efﬁciency of approximately 30% (Fig. 2F).
The post-cleavage crystal structure of NS2 suggests that dimer-
isation is required for the activity of the autoprotease [20]. It is
plausible that the inactivity of the two mutants was due to defects in
the ability to dimerise. To test this, we investigated dimer formation
by glutaraldehyde cross-linking (Fig. 3). As demonstrated by the
appearance of increasing amounts of WT NS2-3 dimer, cross-linking
increased in a dose-dependent manner with increasing concentra-
tions of glutaraldehyde. It appears that the rate and the efﬁciency of
dimerisation of WT NS2-3 and C997A are similar, but with great
contrast to that observed with H956A which exhibited a lower efﬁ-
ciency for dimer formation. This initial observation highlights simi-
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cross-linking, however, is simply dependent on the likelihood that
the reactive groups are close together; therefore, little information
about the overall protein folds can be derived solely from these
experiments.
Direct comparison of any differences in the folding properties of
the WT protease and the mutants requires analysis of WT NS2-3 in a
pre-cleavage state. The auto-cleavage of JFH-1 NS2-3 protease, unlike
J4 NS2-3, does not proceed at 4 °C (Fig. 2F); therefore, this made it
possible to assess and compare the folding of WT and mutant NS2-3
pre-cleavage. To investigate whether refolding at low temperature
had any differential effect on the conformation of the protease com-
pared to that at 25 °C, we measured the ﬂuorescence emission spectraFig. 4. Fluorescence emission spectra of wild-type and mutant NS2-3 precursor. (A) Compari
(solid line), and refolded (dashed line), conditions. Low temperature inhibits activity but all
maximum of NS2-3. (B) Inhibition of activity by zinc chelation is directly linked to the lack
active site mutants H956A and C997A.of denatured and refolded WT NS2-3 precursor at 25 °C and at 4 °C
after excitation at 295 nm. The emission spectra of denatured WT
NS2-3 at the two temperatures show similar emission maxima
(373 nm at 25 °C, 371 nm at 4 °C) and intensities demonstrating
that the polarity of the microenvironment around the tryptophan
residues of NS2-3 at the two temperatures is similar (Fig. 4A). Upon
refolding overnight at 4 °C or 25 °C, wild-type NS2-3 exhibited both a
decrease in the tryptophan ﬂuorescence intensity and a blue shift of
the maximal emission wavelength to 342 nm, indicating that the
environment around the tryptophan residues had become more
hydrophobic (Fig. 4A). The folding of the NS2-3 precursor therefore
occurs at 4 °C; this temperature represents a suitable condition under
which to study the conformation of the precursor state of the wild-son of the ﬂuorescence emission spectra of WT NS2-3 at 4 °C or 25 °C under denaturing
ows folding of the NS2-3 precursor. The vertical line indicates the tryptophan emission
of refolding in the presence of 10 mM EDTA. (C) Fluorescence emission spectra of the
218 T.L. Foster et al. / Biochimica et Biophysica Acta 1804 (2010) 212–222type enzyme. Comparisons of the ﬂuorescence properties of the WT
protease with those of the mutants at 4 °C were therefore assessed
and detailed in section 3.3.
WT NS2-3 has been reported to show no auto-cleavage in the
absence of zinc [13]. The ability of the divalent metal ion chelator
EDTA to inhibit auto-cleavage suggests that the presence of the Zn2+
ion within NS3 is required [13]. Addition of 10 mM EDTA to the
cleavage buffer resulted in inhibition of both activity and folding of
the enzyme; the ﬂuorescence emission spectra after excitation at
295 nm showed that the NS2-3 precursor after overnight incubation
remained in the unfolded state (Fig. 4B), consistent with the lack of
cleavage observed by western blot (Fig. 2E). This ﬁnding provides
direct evidence that zinc plays an important structural role in the
correct folding of the NS2-3 precursor.
3.3. Active site mutations affect the global fold of the NS2-3 protease
The intrinsic tryptophan ﬂuorescence of the wild-type enzyme
was compared with those of the active site mutants H956A and
C997A. On excitation of the denatured NS2-3 precursors at 295 nm,
no signiﬁcant differences in the peak emission wavelength around
377 nm were detected between the wild-type and the mutants
demonstrating that the environment for each protein in the un-
folded state is similar. It is expected that in all cases, the proteins
will be fully extended in denaturant and therefore tryptophan
residues will be exposed in this environment (Fig. 4A, C). However,
the changes in the relative ﬂuorescence intensities and shifts in the
maximal emission wavelengths of the refolded mutants (370 nm for
H956A and 358 nm for C997A) were less marked compared to the
wild-type (Fig. 4A, C). The latter suggests that in contrast to wild-
type NS2-3, upon incubation in refolding buffer, the tryptophan
residues of the mutants remain exposed to a more polar envi-
ronment; hence, the mutant precursor state is a more solvent-
exposed conformation in comparison to the WT NS2-3 precursor.
The highest emission maximum was observed for H956A signify-
ing that the tryptophan residues in this particular protein con-
formation exist in a more polar environment relative to C997A and
WT NS2-3.
The secondary structure characteristics of the NS2-3 precursor
state were investigated by circular dichroism. Auto-cleavage under
the refolding conditions used for the circular dichroism analysis, i.e.,
in the presence of sodium phosphate buffer and DTT, was assessed by
western blot. Cleavage was observed as expected at room tempera-
ture but not at 4 °C (data not shown). The far-UV CD spectra of the
denatured precursors show that no secondary structure character-Fig. 5. Far-UV CD spectra of WT NS2-3 and active site mutants C997A and H956A. The
spectra were recorded at 4 °C under denaturing (6 M Gdn-Cl) and refolding buffer
conditions.istics can be observed in 6 M Gdn-Cl for any of the unfolded proteins
(Fig. 5). Upon refolding, the NS2-3 precursors yielded very noisy CD
spectra due to the high chloride ion, glycerol and detergent content
of the refolding buffer especially below 215 nm. However, the
shape and intensity of the spectra still allowed comparisons between
the WT and mutant proteins. The spectra show that WT NS2-3 has
some α-helical secondary structure characteristics with a minimum
around 222 nm. The CD data also show that C997A has very similar
secondary structure characteristics to the WT protein with the
spectrum resembling that of theWT precursor state. H956A, however,
appears to lack any secondary structure characteristics in the region of
the spectrum that can be analysed, implying that H956A may be in an
unfolded state and lack any α-helical similarities to the WT precursor
(Fig. 5).
3.4. Quenching of the intrinsic ﬂuorescence emission of NS2-3
precursors
The degree of accessibility of the tryptophan residues in the WT
and mutant precursor states can be investigated by ﬂuorophore
quenching studies. Quenching experiments were carried out using
the neutral quencher acrylamide, which is highly sensitive to the
extent of tryptophan exposure to the solvent. Quenching of trypto-
phan ﬂuorescence by acrylamide may result from accessibility of
tryptophan residues on the surface of the protein or from the
accessibility of residues through channels that lead to the interior of
the protein.
The ﬂuorescence emission spectra of denatured and refolded
wild-type NS2-3, H956A and C997A mutants were recorded in the
absence and presence of increasing concentrations of acrylamide
(Fig. 6); as expected, a progressive decrease in the ﬂuorescence
intensity was observed with increasing quencher concentration. The
spectra of each NS2-3 precursor indicate that the extent of quenching
is higher in the presence of GdnHCl, indicating that in the unfolded
state the tryptophan residues are more accessible. The tryptophan
residues in the refolded WT NS2-3 precursors are accessible to
acrylamide, yet differences in the extent of quenching of C997A and
H956A are observed, indicating that the ﬂuorophores of WT NS2-3
are in a more hydrophobic environment. Notably, the extent of
quenching achieved by acrylamide with refolded H956A is not
signiﬁcantly different to that of H956A in the denatured state. These
data clearly indicate that the tryptophan residues are experiencing a
similar environment when in denaturant and when under refolding
conditions in this mutant.
The Stern–Volmer relationships for WT NS2-3 and mutants are
plotted in Fig. 7 and quenching constants were determined for each
NS2-3 protein in the denatured and refolded states (Table 1). In the
denatured state, linear Stern–Volmer plots were observed for all
proteins indicating that a homogenous population of ﬂuorophores is
being quenched. The NS2-3 precursors possess similar quenching
patterns and share similar quenching constants demonstrating that
comparable extended and ﬂexible conformations are adopted by
the NS2-3 precursors when in the presence of strong denaturant
(Fig. 7A). As in the unfolded state, a linear Stern–Volmer relationship
was observed for refolded H956A, in addition the highest quenching
constant was observed for H956A (6.48 M−1) (Fig. 7B), relative to
WT and C997A, suggesting that the structure of this mutant is more
open and dynamic allowing easy interaction of acrylamide with the
tryptophan ﬂuorophores. Upon refolding, biphasic or non-linear
quenching patterns are observed for WT NS2-3 and C997A pre-
cursors, indicating that dynamic ﬂuorescence quenching of multiple
groups of tryptophan residues in different accessible environments
is being observed (Fig. 7B). Modiﬁed Stern–Volmer plots were
used to determine the fraction of accessible tryptophan ﬂuoro-
phores, fa, and the quenching constant KSV, for WT NS2-3and C997A
by plotting F0/(F0−F) versus 1/[Q] (data not shown). The plots
Fig. 6. Fluorescence emission spectra of wild-type and mutant NS2-3 precursor in the absence and presence of acrylamide under denaturing conditions and refolded in cleavage
buffer. The effect of increasing concentrations of acrylamide from a 5-M stock on the tryptophan emission of WT NS2-3 and mutants is represented as a percentage of the
ﬂuorescence at the maximal wavelength. Plots of percentage intensity against acrylamide quencher concentration are shown, where black=0 M, blue=0.025 M, red= 0.05 M,
green= 1M, orange= 0.2M and purple= 0.5M. Experimentswere performed in triplicate and the standard errors among values at each acrylamide concentration are shown inset.
Plots were ﬁtted using the exponential equation y=y0+Ae(bx) in OriginPro8 (OriginLab).
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The data reported in Table 1 show that all of the tryptophan resi-
dues of H956A are accessible to the acrylamide quencher, fa=1.0.
Contrastingly, a smaller fraction of the tryptophan residues of
WT NS2-3 and C997A are observed to be accessible; fa values= 0.57
and 0.75, respectively. These results are consistent with the CD
data presented earlier showing that H956A does not have the
secondary structure characteristics of the C997A and WT NS2-3
precursors.4. Discussion
The NS2-3 precursor is an ideal target for the development of
novel HCV anti-viral therapies. Structural information about the
autoprotease precursor is required for understanding the protease
mechanism and two mutants within NS2, His956A and Cys997A,
have been identiﬁed as candidates for trapping NS2-3 in the
precursor state. The crystal structure of the post-cleavage state
shows His956 and Cys997 as part of a composite active site in an NS2
Fig. 7. Stern–Volmer plots comparing the quenching of NS2-3 precursors WT (○),
H956A (▴) and C997A (▪) in the presence of acrylamide in denatured (A) and refolded
states (B). Plots were derived using the linear equation y=a+bx in OriginPro8
(OriginLab). The standard errors of the averages from three separate experiments are
plotted. Under refolded conditions, non-linear Stern–Volmer relationships were
observed for WT and C997A NS2-3; therefore, the accessibility of the tryptophan
ﬂuorophores to the quencher and the quenching constants under refolding conditions
were derived from modiﬁed Stern–Volmer plots where F0/(F0−F) versus 1/[Q] was
plotted (data not shown).
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dimer required for activity [20]. As a consequence, mutation of these
residues to alanine (H956A and C997A) might be expected to have
signiﬁcant consequences not only for enzymatic function, but also for
the formation of the catalytically active pre-cleavage protein
conformation. This article describes the ﬁrst biophysical character-
isation of the precursor state of the NS2-3 protein and its active site
mutants.
Using recombinantly expressed NS2-3 protein of genotype 2a, we
characterised NS2-3 in its pre-cleavage state using low temperature
and optimisation of the refolding conditions (Fig. 2). The microenvi-
ronment of protein residues is conditional on a variety of physical and
chemical characteristics due to speciﬁc interactions, neighbouring
residues, charged groups and polarizability, inﬂuencing the overall
ﬂuorescence of the protein. The restricted conditions required for
NS2-3 refolding, i.e., high detergent, glycerol and salt concentrations,Table 1
Accessibility of tryptophan residues of WT NS2-3 and active site mutants H956A and
C997A to the quencher acrylamide.
NS2-3 precursor Refolded Denatured
KSV fa KSV
Wild-type 2.76 ± 0.52 0.57 ±0.3 12.9 ± 0.43
C997A 3.56 ± 0.48 0.75 ±0.2 9.92 ± 0.41
H956A 6.48 ± 0.4 1.0±0.3 9.22 ± 0.33
Both the ﬂuorescence accessible to the quencher fa, and quenching constants KSV, are
detailed for WT NS2-3 and active site mutants. Values are averages from three
independent experiments and standard error values have been calculated.are not amenable to typical conformational and folding analysis by, for
example, circular dichroism, Fourier transform infrared spectroscopy
(FTIR) or dynamic light scattering techniques. Tryptophan ﬂuoro-
phores are, however, particularly sensitive to their environment;
hence, these residues act as useful structural probes [22,23]. A total of
ﬁve tryptophan residues are located in the NS2-3 precursor, three in
the NS2 cytoplasmic domain and two in the NS3 protease domain; as
shown in Fig. 8, it appears that in the folded post-cleavage structures
of NS2 and NS3 [20,24], the tryptophan residues are in both buried
and solvent-exposed regions. Here we have assessed the pre-cleavage
conformation during refolding of the NS2-3 precursors under various
conditions where the protein can undergo auto-cleavage, those where
auto-cleavage is inhibited and the folding of the inactive mutants
H956A and C997A. Importantly, performing the refolding reaction of
WT NS2-3 at 4 °C prevented auto-cleavage but allowed conservation
of the overall precursor fold, in comparison to the chelation of zinc
which abrogated both cleavage and folding of the enzyme. The
conformational changes that affect refolding in the case of C997A can
also be distinguished from those observed for WT NS2-3 in the
presence of the zinc chelator EDTA and from those of the mutants in
which the cleavage site residues Leu1030 and Ala1031 have been
changed to proline (LAPP) [11,13]—these exhibit a tryptophan
ﬂuorescence proﬁle similar to that of H956A (data not shown).
The results presented here suggest that the inactive mutants have
considerable differences in their tertiary structure around the
tryptophan residues, possibly in both the NS2 and NS3 subdomains,
in addition to the loss of auto-catalytic activity observed. The two
active site mutants, however, do not appear to be experiencing the
same global conformational changes in their structure during
refolding as the ﬂuorescence shifts observed for C997A are closer to
those of the wild-type enzyme than to H956A. The CD measurements
conducted were affected by the refolding buffer conditions required
for NS2-3 refolding and activity. Despite this, it was observed that the
secondary structure content of C997A is comparable to that of the WT
NS2-3 precursor protein. H956A did not appear to possess any
secondary structure characteristics under these conditions (Fig. 5).
The increase in the KSV value for the mutant precursor proteins from
the wild-type value and the increase in accessibility of the quencher
acrylamide to the core of the proteins indicated that the precursor
state formed by the mutant NS2-3 proteins was in the incorrect
conformation in which cleavage was unable to occur.
In cysteine proteases, the catalytic triad, in NS2-3 proposed to be
C997-H956-E976 [20], forms a stable charge relay system that serves
to increase the nucleophilic properties of the active cysteine and to
stabilise the transition state [25]. As the active site mutations C997A
and H956A abrogate activity, as assessed on the basis of in vitro
function using gel based assays, this has been viewed as conﬁrmation
of their active site roles [15,17]. However, from the ﬁndings reported,
it is clear that these two amino acids play an important role in
maintaining the integrity of the active site conformation and this
importance extends to the global fold of NS2-3 precursor. The mutant
H956A, in particular, appears to cause severe disruption to protein
folding in addition to the loss of enzymatic activity. From the post-
cleavage structure, H956 makes many hydrogen bond contacts
compared to C997, the loss of which would explain the loss of activity
and fold on mutation. C997A appears to have a more native-like fold
but the quenching experiments show that it is less tightly folded than
the wild-type protease, making it a folding mutant. These data would
also suggest that future studies aimed at elucidating structural
information about the NS2-3 precursor would beneﬁt from using
C997A or low temperature to inhibit auto-cleavage, rather than
H956A or the sequestration of zinc.
This study serves to illustrate a wider point that the loss of activity
exhibited in mutants of putative active site residues may not solely
result from a loss of catalytic activity but can also be related to gross
changes in the global protein fold. Although C997A and H956A appear
Fig. 8. Location of the ﬁve tryptophan residues in the NS2 (A) and NS3 (B) subdomains of the genotype 1a NS2-3 precursor. The ﬁgure was generated using Pymol version 0.99 and
the coordinates of PDB code 2hd0 (A) [20] and 1a1r (B) [24]. The tryptophan ﬂuorophores are shown in red in stick representation and surface representation. Carbon and backbone
ribbon are coloured in black for monomer A and grey for monomer B in the NS2 subdomain.
221T.L. Foster et al. / Biochimica et Biophysica Acta 1804 (2010) 212–222to be loss of functionmutants, our detailed experiments reported here
show that these mutants alone are insufﬁcient for studying the
activity and mechanism of the NS2-3 protease. Additional mutants
that inhibit cleavage but maintain tertiary structure will need to be
probed for further molecular level investigations into HCV NS2-3
biology, a conclusion that likely holds true for many proteins.
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